Related Experiment Video
Updated: Nov 16, 2025

Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice
Published on: March 10, 2015
Clinical applications of artificial intelligence and machine learning-based methods in inflammatory bowel disease
Shirley Cohen-Mekelburg1,2, Sameer Berry2, Ryan W Stidham2,3,4
1Health Services Research and Development Center of Clinical Management Research and Gastroenterology Service, VA Ann Arbor, Ann Arbor, Michigan, USA.
Artificial intelligence (AI) can enhance inflammatory bowel disease (IBD) care by reducing variations and improving outcomes. Further research is needed to fully realize AI's transformative potential in IBD management.
Area of Science:
- Medical Informatics
- Artificial Intelligence in Medicine
- Gastroenterology
Background:
- Inflammatory bowel disease (IBD) presents complex challenges with significant variations in patient care and outcomes.
- Artificial intelligence (AI) offers a promising avenue to address these complexities and standardize healthcare delivery.
- The integration of AI in IBD management is crucial for improving patient care quality.
Purpose of the Study:
- To review and exemplify AI applications that can improve inflammatory bowel disease (IBD) care.
- To identify current gaps and future research directions for AI in IBD.
- To highlight AI's potential to reduce healthcare variations and enhance patient outcomes.
Main Methods:
- Literature review of selected AI applications in IBD.
- Exemplification of AI's role in IBD pathogenesis, diagnosis, and prognosis.
- Analysis of AI's capabilities in mimicking human intelligence for clinical decision-making.
Main Results:
- AI applications show potential in studying IBD pathogenesis, diagnosis, and prognosis.
- AI can aid in reducing variability in IBD healthcare delivery.
- Early-stage AI development in IBD demonstrates significant potential for future transformation.
Conclusions:
- AI holds immense potential to revolutionize inflammatory bowel disease (IBD) care.
- Addressing current research gaps will accelerate the adoption of AI in IBD.
- AI can lead to more consistent and improved patient outcomes in IBD management.
More Related Videos
09:44Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis
Published on: October 14, 2025
07:05Fluorescence-mediated Tomography for the Detection and Quantification of Macrophage-related Murine Intestinal Inflammation
Published on: December 15, 2017
Related Concept Videos
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...